Promising new research suggests targeting the endocannabinoid system to treat cognitive disorders

(Natural News) Spanish researchers found new hope for patients with cognitive disorders like Down syndrome. Their experiment on cognitively-impaired mice revealed a link between Down syndrome and the endocannabinoid system. Furthermore, they identified cannabinoid receptor type-1 (CB1R) as a possible target for the treatment of Down syndrome. Mental disability stems from many causes, including genetic problems. The most...

from NaturalNews.com https://ift.tt/2K9AHKk